Foresite Capital

Activity from announced rounds

Activity in this selectionAI

Foresite Capital is a healthcare investment firm identified by Abcuro and in its own Thyme Care portfolio record.

Recorded funding activity

Abcuro develops immunotherapies targeting pathogenic cytotoxic T cells. Thyme Care combines oncology care teams with technology, while Khartis develops oral medicines for immune and chronic diseases. The company histories distinguish care delivery from experimental drug development.

Sources
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$155M
2 disclosed · full round size, not this investor’s share

By stage

Series C+2

By primary sector

Healthtech2

By country

United States2

Rounds

2 in this selection
Stepful

Offers accelerated, affordable training for healthcare careers

$55MSeries C
Role not disclosed
Midi Health

Provides accessible, insurance-covered services in all 50 states for women's healthcare

$100MSeries D
Role not disclosed